U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Teva Pharmaceuticals USA, Inc. |
---|---|
Address | Building A 400 Interpace Parkway Parsippany,NJ 07054 |
Date | Description | Action Tags | Code |
---|---|---|---|
Oct-05-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Oct-03-2023 | SOU EXTENSION 4 GRANTED | EX4GS | |
Oct-03-2023 | SOU EXTENSION 4 FILED | EXT4S | |
Oct-03-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Mar-31-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Mar-29-2023 | SOU EXTENSION 3 GRANTED | EX3GS | |
Mar-29-2023 | SOU EXTENSION 3 FILED | EXT3S | |
Mar-29-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Sep-24-2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Sep-22-2022 | SOU EXTENSION 2 GRANTED | EX2GS | |
Sep-22-2022 | SOU EXTENSION 2 FILED | EXT2S | |
Sep-22-2022 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Apr-06-2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Apr-04-2022 | SOU EXTENSION 1 GRANTED | EX1GS | |
Apr-04-2022 | SOU EXTENSION 1 FILED | EXT1S | |
Apr-04-2022 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
Oct-05-2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Aug-10-2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Aug-10-2021 | PUBLISHED FOR OPPOSITION | PUBOA | |
Jul-21-2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Jul-02-2021 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Jul-01-2021 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
Jul-01-2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
Jul-01-2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
Jan-06-2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | GNRNO | |
Jan-06-2021 | NON-FINAL ACTION E-MAILED | GNRTF | |
Jan-06-2021 | NON-FINAL ACTION WRITTEN | CNRTR | |
Dec-28-2020 | ASSIGNED TO EXAMINER | DOCKD | |
Sep-30-2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Aug-31-2020 | NEW APPLICATION ENTERED | NWAPI |